Latest Schedule 13G passive stakes

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have jointly filed a Schedule 13G, reporting beneficial ownership of 4,893,883 shares, or 4.3%, of Perspective Therapeutics, Inc. common stock.

Galloway Capital Partners, LLC, Galloway Capital, LP, and Bruce Galloway have collectively reported beneficial ownership of 764,000 shares of T Stamp Inc. common stock, representing 13.64% of the outstanding shares.

Linden Capital L.P., Linden GP LLC, Linden Advisors LP, and Siu Min Wong have jointly filed a Schedule 13G, reporting beneficial ownership of 6.3% to 6.5% of Columbus Circle Capital Corp II's Class A Ordinary Shares as of June 26, 2026.

Tang Capital Management, LLC and affiliated entities have reported beneficial ownership of 11.3% of Boundless Bio, Inc.'s common stock.

Millennium Management LLC, along with affiliated entities and Israel A. Englander, has filed a Schedule 13G, reporting beneficial ownership of 4.7% of Maravai LifeSciences Holdings, Inc. Class A Common Stock.

HRTG entities and individuals report beneficial ownership of 18.2% of Kardigan, Inc. common stock, excluding certain warrant shares.

Minerva Advisors LLC and affiliated entities have reported beneficial ownership of 149,410 shares, representing 5.2% of Kewaunee Scientific Corporation's outstanding common stock.

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have jointly filed a Schedule 13G, reporting beneficial ownership of 3.6% of BellRing Brands, Inc. common stock as of June 23, 2026.

Jeal Intec, S.L. and Jesus Alonso Villaron report 0% beneficial ownership of ProPetro Holding Corp. common stock as of December 31, 2025.

Inspired Capital Partners and affiliated entities have reported a beneficial ownership stake of 6.4% in Teamshares Inc. common stock.

Multiple entities and individuals associated with Situational Awareness LP have jointly reported beneficial ownership of 19.9% of SharonAI Holdings Inc.'s Class A Ordinary Common Stock.

Opaleye Management Inc., Opaleye L.P., and James Silverman have jointly filed a Schedule 13G, reporting beneficial ownership of 2,895,107 shares of Alpha Cognition Inc. common stock, representing 13.30% of the class.

BML Investment Partners, L.P. has reported a beneficial ownership of 2.5% in Oramed Pharmaceuticals Inc., holding 1,026,269 shares.

CVI Investments, Inc. and Heights Capital Management, Inc. have jointly filed a Schedule 13G, reporting beneficial ownership of 9.9% of Westport Fuel Systems Inc. common shares.

Whitebox Advisors LLC and Whitebox General Partner LLC have filed a Schedule 13G reporting an 8.5% beneficial ownership stake in Maxeon Solar Technologies, Ltd.

Individual investor Jerzy Stanislaw Wojcik has filed a Schedule 13G reporting a 19.6% beneficial ownership stake in Aditxt, Inc.

Spark Capital Growth Fund III and affiliates have reported a 5.1% beneficial ownership stake in Teamshares Inc. common stock.

A group of related entities led by David Capobianco disclosed a 52.1% beneficial ownership stake in WaterBridge Infrastructure LLC.

Morgan Stanley has filed a Schedule 13G reporting a 7.5% beneficial ownership stake in Zepp Health Corp.

Morgan Stanley has filed a Schedule 13G reporting a 7.5% beneficial ownership stake in Zepp Health Corp.

Millennium Management LLC and Israel A. Englander have reported a 5.1% beneficial ownership stake in LENZ Therapeutics, Inc.

Catheter Precision, Inc. has filed a Schedule 13G reporting a 7.5% beneficial ownership stake in Volato Group, Inc. following a private placement.

Catheter Precision, Inc. has filed a Schedule 13G reporting a 7.5% beneficial ownership stake in Volato Group, Inc. following a private placement.

QED Growth Fund, L.P., QED Partners Growth, LLC, and Nigel Morris have filed a Schedule 13G reporting an 8.3% beneficial ownership stake in Teamshares Inc.

A group of investment funds managed by USV have collectively disclosed a 3.3% beneficial ownership stake in Teamshares Inc. common stock.

Paradigm BioCapital Advisors LP and affiliates have reported a 5.1% beneficial ownership stake in Viridian Therapeutics, Inc.

MMCAP International Inc. SPC and MM Asset Management Inc. have filed a Schedule 13G reporting a 6.5% beneficial ownership stake in Wilco 63 Corp.

Capital Ventures International, Susquehanna Advisors Group, and Susquehanna Securities have filed a Schedule 13G reporting an 11% beneficial ownership stake in Quantum eMotion Corp.

CVI Investments, Inc. and Heights Capital Management, Inc. have filed a Schedule 13G reporting a 5.5% beneficial ownership stake in CervoMed Inc.

Feis Equities LLC and Lawrence M. Feis have filed a Schedule 13G reporting a 5.08% beneficial ownership stake in Drugs Made In America Acquisition Corp.